Safety and Efficacy of Current DAA Regimens in Kidney and Liver Transplant Recipients with Hepatitis C: Results from the HCV-TARGET Study

BACKGROUND: Data outside of clinical trials with direct acting antiviral (DAA) regimens with or without ribavirin as treatment of chronic HCV in solid organ transplant recipients is limited. METHODS: Liver transplant (LT), kidney transplant (KT) and dual liver kidney (DLK) transplant recipients from...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Hepatology
Κύριοι συγγραφείς: Saxena, Varun, Khungar, Vandana, Verna, Elizabeth C., Levitsky, Josh, Brown, Robert S., Hassan, Mohamed A., Sulkowski, Mark S., O’Leary, Jacqueline G., Koraishy, Farrukh, Galati, Joseph S., Kuo, Alexander A., Vainorius, Monika, Akushevich, Lucy, Nelson, David R., Fried, Michael W., Terrault, Norah, Reddy, K.Rajender
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2017
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5756478/
https://ncbi.nlm.nih.gov/pubmed/28504842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.29258
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια